GlassScriptPhysician profile
Arjun Chadha
NPI 1689324931
$5,455.30
in general payments reported to CMS, 2019-2025
25 companies · $2,875 in 2025
The $2,875 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $293 · 2023: $974 · 2024: $1,313 · 2025: $2,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,849 · Grant: $1,000 · Education: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,849.37 |
| Grant | $1,000.00 |
| Education | $312.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,242.06 | 2025 | Assurity, Ensite |
| Janssen Pharmaceuticals, INC | $557.54 | 2023-2024 | Xarelto |
| Genzyme Corporation | $521.93 | 2022-2025 | |
| Penumbra, INC. | $425.52 | 2024-2025 | Indigo System |
| Philips North America LLC | $350.67 | 2024-2025 | Azurion 7 M20, Encore, (5044) Mcot |
| Emd Serono, INC. | $286.94 | 2022-2025 | |
| Boston Scientific Corporation | $271.95 | 2023-2025 | Eluvia, Ranger |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $271.29 | 2023-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $217.38 | 2023-2025 | Opsumit, Uptravi |
| Inari Medical, INC. | $177.59 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Nevro Corp. | $169.21 | 2024 | Senza |
| Pfizer INC. | $154.79 | 2022-2025 | |
| Abbvie INC. | $139.02 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $128.83 | 2024-2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $124.74 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $118.77 | 2022 | |
| Medtronic, INC. | $67.30 | 2024 | Cobalt Dr Mri Surescan |
| Novo Nordisk INC | $63.00 | 2025 | |
| Abiomed | $34.13 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $33.74 | 2023 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals, LTD. | $27.37 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $24.75 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Neurelis, INC. | $17.03 | 2024 | Valtoco |
| Kiniksa Pharmaceuticals International, Plc | $15.56 | 2024 | Arcalyst |
| Terumo Medical Corporation | $14.19 | 2023 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Chadha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.